Viska Bio
- Biotech or pharma, therapeutic R&D
Viska is finalist for BIO's Start Up Stadium event. Join us for our presentation and Q&A on Thursday, June 19th, at 11am.
We are also hosting a Happy Hour event at Cisco Brewery on Monday, June 16th from 4-7 PM to facilitate further engagement between the start-up community with the larger biotech, pharma, and investor ecosystem. We would love to see you there.
Viska Bio is pioneering the use of targeted extracellular oxidative damage to change how tumors respond to immunotherapies. Our nanobody-enzyme fusion protein platform is designed to trigger the release of immune-stimulatory molecules that promote lymphocyte recruitment through a unique replication-independent mechanism of action. We are seeking meetings with VCs and biotech or pharma partners that would be interested in a research collaboration.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}